P 1025

Drug Profile

P 1025

Latest Information Update: 24 Jan 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator United Medical and Dental Schools of Guys, Kings and St Thomas Hospitals
  • Developer Active Biotech; United Medical and Dental Schools of Guys, Kings and St Thomas Hospitals
  • Class Peptides
  • Mechanism of Action Cell adhesion molecule inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Dental caries

Most Recent Events

  • 24 Jan 2017 Discontinued - Preclinical for Dental caries in United Kingdom (Topical)
  • 14 Dec 2000 Actinova has been closed down
  • 14 Dec 2000 Suspended-Preclinical for Dental caries in United Kingdom (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top